94 studies found for:    Open Studies | "Urinary Bladder, Overactive"
Show Display Options
Rank Status Study
21 Not yet recruiting A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 5 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)
Conditions: Neurogenic Detrusor Overactivity;   Overactive Bladder
Intervention: Drug: mirabegron
22 Recruiting A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron OCAS (Oral Controlled Absorption System) in Pediatric Subjects With Neurogenic Detrusor Overactivity or Overactive Bladder
Conditions: Pharmacokinetics of Mirabegron;   Neurogenic Detrusor Overactivity;   Overactive Bladder
Intervention: Drug: Mirabegron
23 Unknown  A Randomized, Placebo-Controlled Study to Assess the Efficacy of Propantheline for the Treatment of Overactive Bladder
Condition: Overactive Bladder Associated With HTLV-1
Interventions: Drug: Propantheline Bromide;   Drug: Placebo
24 Not yet recruiting Brain Areas Involved in Bladder Filling and Contraction
Condition: Urinary Bladder, Overactive
Interventions: Procedure: Uroflowmetry;   Device: fMRI
25 Unknown  Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
Condition: Overactive Bladder Syndrome
Intervention: Drug: Solifenacin
26 Unknown  Pilot Study: Is Overactive Bladder Caused by Subacute Urinary Tract Infections?
Condition: Overactive Bladder
Intervention:
27 Recruiting MIrabegron With oveRACtive bLadder Symptoms in mEn
Condition: Overactive Bladder
Interventions: Drug: mirabegron;   Drug: placebo
28 Recruiting OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: OnabotulinumtoxinA
29 Not yet recruiting Educating Patients on Management of Overactive Bladder: Written Versus Verbal Instructions
Condition: Overactive Bladder
Intervention: Other: Written List
30 Recruiting An Observational Study of BOTOX® for the Management of Urinary Incontinence in Patients With Idiopathic Overactive Bladder
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A
31 Not yet recruiting The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides
Condition: Overactive Bladder
Intervention: Drug: conjugated estrogen
32 Recruiting The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder
Condition: Overactive Bladder
Intervention: Other: Botulinum toxin and cineMRI-UDS
33 Recruiting "The Effects of Caffeine on Overactive Bladder Symptoms and Mental Health in Postmenopausal Women"
Conditions: Overactive Bladder;   Caffeine;   Menopause
Interventions: Dietary Supplement: 400 mg of caffeine/day (Two 200mg pills/day);   Dietary Supplement: 200 mg of caffeine/day (One 200mg pill and one placebo pill);   Dietary Supplement: Two placebo pills/day
34 Recruiting Evaluation of Safety and Efficacy of Botulinum Toxin Type A (BOTOX®) to Treat Urinary Incontinence Due to Neurogenic Detrusor Overactivity or Overactive Bladder in Korea
Conditions: Urinary Incontinence;   Urinary Bladder, Overactive
Intervention: Biological: botulinum toxin Type A
35 Recruiting Different Injection Number of the Same Dose of Botulinum Toxin A on Overactive Bladder Syndrome
Condition: Overactive Bladder
Interventions: Drug: BoNT-A (10 injection);   Drug: BoNT-A (20 injection);   Drug: BoNT-A (40 injection)
36 Recruiting The Effect and Safety of Moxibustion Therapy for Overactive Bladder Patients
Conditions: Overactive Bladder;   Hyperthermia;   Urinary Frequency or Urgency Adverse Event;   Lower Urinary Tract Symptoms
Intervention: Device: moxibustion
37 Recruiting Secondary Bilateral Sacral Nerve Stimulation in Overactive Bladder Patients
Condition: Bladder Hyperactivity
Intervention: Device: Device:   INTERSTIM II
38 Unknown  Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder
Condition: Overactive Bladder
Intervention: Behavioral: Health education intervention (HEI)
39 Unknown  Botox for the Treatment of Overactive Bladder Secondary to Benign Prostatic Obstruction
Condition: Overactive Bladder
Intervention: Drug: Botox/Placebo
40 Recruiting Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
Condition: Overactive Bladder
Intervention: Drug: Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years